blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2328570

EP2328570 - METHOD AND FORMULATION FOR TREATING ADVERSE BIOLOGICAL CONDITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.04.2014
Database last updated on 02.07.2024
Most recent event   Tooltip18.04.2014Application deemed to be withdrawnpublished on 21.05.2014  [2014/21]
Applicant(s)For all designated states
Livionex Inc.
104 Milani Court
Los Gatos, CA 95030 / US
[2011/23]
Inventor(s)01 / BHUSHAN, Rajiv
3838 Mumford Place
Palo Alto CA 94306 / US
02 / GIN, Jerry, B.
1206 Sargent Drive
Sunnyvale CA 94087 / US
03 / GOSWAMY, Amit
104 Milani Court
Los Gatos CA 95030 / US
 [2011/23]
Representative(s)Mallalieu, Catherine Louise, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2011/23]Mallalieu, Catherine Louise, et al
D Young & Co LLP 120 Holborn
London EC1N 2DY / GB
Application number, filing date09806991.717.08.2009
[2011/23]
WO2009US04709
Priority number, dateUS20080189060P15.08.2008         Original published format: US 189060 P
[2011/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010019276
Date:18.02.2010
Language:EN
[2010/07]
Type: A2 Application without search report 
No.:EP2328570
Date:08.06.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 18.02.2010 takes the place of the publication of the European patent application.
[2011/23]
Search report(s)International search report - published on:KR03.06.2010
(Supplementary) European search report - dispatched on:EP26.09.2012
ClassificationIPC:A61K31/10, A61K48/00, A61K31/7105, A61K39/395, A61K38/19, A61P35/00, A61P3/10
[2011/23]
CPC:
A61K31/10 (EP,US); A61K31/7105 (EP,US); A61K48/0008 (EP,US);
A61P3/10 (EP); A61P35/00 (EP); A61P43/00 (EP);
C12N15/87 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/23]
TitleGerman:VERFAHREN UND FORMULIERUNG ZUR BEHANDLUNG UNERWÜNSCHTER BIOLOGISCHER ZUSTÄNDE[2011/23]
English:METHOD AND FORMULATION FOR TREATING ADVERSE BIOLOGICAL CONDITIONS[2011/23]
French:PROCÉDÉ ET FORMULATION DE TRAITEMENT D'ÉTATS BIOLOGIQUES INDÉSIRABLES[2011/23]
Entry into regional phase14.03.2011National basic fee paid 
14.03.2011Search fee paid 
14.03.2011Designation fee(s) paid 
14.03.2011Examination fee paid 
Examination procedure14.03.2011Examination requested  [2011/23]
25.04.2013Amendment by applicant (claims and/or description)
28.05.2013Despatch of a communication from the examining division (Time limit: M06)
10.12.2013Application deemed to be withdrawn, date of legal effect  [2014/21]
08.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/21]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.05.2013
Fees paidRenewal fee
31.08.2011Renewal fee patent year 03
27.09.2012Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.08.201204   M06   Fee paid on   27.09.2012
31.08.201305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2008099397  (DERMA YOUNG LTD [IL], et al) [XP] 1-18 * page 18, line 23 - line 30 *
International search[X]US2006177430  (BHUSHAN RAJIV [US], et al);
 [A]US6403116  (ANDERSON MARK L [US], et al);
 [A]WO2004002534  (NOVO NORDISK AS [DK]);
 [A]WO2007149287  (RAMAEKERS NUTRITION LLC [US], et al);
 [A]EP1254961  (TRANSGENE SA [FR], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.